Common Sleep Disorders in Pregnancy.
| Autor: | Facco FL; Department of Obstetrics, Gynecology, and Reproductive Sciences and the Center for Sleep and Cardiovascular Outcomes Research, University of Pittsburgh School of Medicine, and the Division of Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Chan M, Patel SR |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Obstetrics and gynecology [Obstet Gynecol] 2022 Aug 01; Vol. 140 (2), pp. 321-339. Date of Electronic Publication: 2022 Jul 06. |
| DOI: | 10.1097/AOG.0000000000004866 |
| Abstrakt: | Compared with men, women have a greater risk of sleep disorders and report higher rates of sleep disturbance. Hormonal and physiologic changes throughout the life span appear to influence a woman's ability to get a good night's sleep. Sleep disturbances are commonly reported during pregnancy, affecting more than one-half of all pregnancies and increasing as gestation progresses. The pervasiveness of sleep complaints during pregnancy may lead to a belief that these symptoms are normal or to be expected. Unfortunately, this perception may impede the accurate diagnosis of sleep disorders during this crucial time. Obstructive sleep apnea, insomnia, and restless legs syndrome are the most common sleep disorders in pregnancy. Sleep disruption in pregnancy can substantially worsen maternal quality of life and may be a risk factor for adverse pregnancy outcomes. This review outlines important considerations for obstetricians taking care of pregnant patients with sleep-related complaints. Competing Interests: Financial Disclosure Francesca L. Facco disclosed receiving consulting fees from Bayer Pharmaceuticals and has received grant support through his institution from Bayer Pharmaceuticals, Philips Respironics, Respicardia and Sommetrics. Sanjay R. Patel disclosed that they and their institution received payment from Bayer Pharmaceuticals and Respicardia. They have an ongoing relationship with Philips Respironics resulting in payments made to their institution, and a current relationship with Sommetrics resulting in payments made to their institution. Sanjay R. Patel disclosed that this manuscript discusses off-label use of carbidopa/levodopa for restless legs syndrome. Megan Chan did not report any potential conflicts of interest. (Copyright © 2022 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|